Christie Medical Innovations Partners with Eclipse Aesthetics

MEMPHIS, Tenn.--(BUSINESS WIRE)-- Christie Medical Innovations today announced the company has partnered with Eclipse Aesthetics, the leading manufacturer and supplier of aesthetic medical products, as a distributor of the VeinViewer® vascular imaging system.

“Our partnership with Eclipse Aesthetics was the perfect step for Christie Medical to take as our VeinViewer platform sees rapid growth among a larger number of aesthetic treatment facilities,” said Chris Schnee, general manager and vice president of sales and marketing at Christie Medical. “The VeinViewer’s capabilities will help improve the level of patient care as well as attract new patients to these practices using the new technology. The long-tenured experience of Eclipse, focused on educating practices to new standards of emerging technologies, makes them an ideal partner.”

Eclipse Aesthetics is a national distributor and manufacturer of medical products that focuses on light-based devices. The company is dedicated to providing groundbreaking products for the aesthetic market, and by doing so, helping practices across the country transform patient care. Eclipse Aesthetics is known for products including the EndyMed PRO®, EQUINOXTM CO2 Fractional Laser and the RegenLab™ autologous skin therapy system. As the VeinViewer is highly regarded for use in sclerotherapy & laser procedures, such as the treatment of varicose and spider veins, it was a natural addition to the product line that Eclipse Aesthetics offers.

“Eclipse Aesthetics is very pleased to partner with such a class organization as Christie Medical in distributing the dynamic VeinViewer vascular imaging technology,” said Tom O’Brian, chief executive officer at Eclipse Aesthetics. “We see the VeinViewer as the perfect technology for the modern aesthetic practice. The device’s capability has proven to enhance outcomes of treatments while creating a huge ‘wow’ factor among patients. We look forward to the excitement the VeinViewer will bring to our aesthetic clients.”

VeinViewer uses harmless near-infrared light and other patented technologies to project a real-time digital image of subcutaneous vasculature directly onto the surface of the skin. Although designed for assistance in IV starts and blood draws, VeinViewer is proven to be beneficial in the process of spider and varicose vein treatment.

To learn more about VeinViewer, visit www.veinviewer.com.

About Christie Medical Innovations

Christie Medical Innovations is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading product, VeinViewer®, is a mobile vascular imaging system that allows health care providers to clearly see accessible vasculature in real time, directly on the surface of the skin. Christie Medical Innovations is owned by Christie Digital Systems, Inc., a global visual technologies company and a subsidiary of Ushio, Inc., Japan (JP:6925). For more information on Christie Digital Systems or Christie Medical Innovations, visit www.christiedigital.com.

About Eclipse Aesthetics

For more than 17 years, Eclipse Aesthetics, LLC headquartered in Dallas, Texas, has been a leading manufacturer and supplier of aesthetic medical products. With an established reputation for bringing transformational products to market, Eclipse continues to serve the United States with meaningful solutions for the aesthetic marketplace. Eclipse's mission is to provide innovative, affordable and quality-based products, which enable the medical aesthetic community to transform their practices in terms of profit, procedures and patient satisfaction. www.eclipsemed.com



CONTACT:

Obsidian Public Relations
Lauren Hannaford, 901-312-7769
[email protected]
or
Christie Medical Innovations
Erin Shelton, 901-252-3700
[email protected]

KEYWORDS:   United States  North America  Tennessee

INDUSTRY KEYWORDS:   Health  Biotechnology  Hospitals  Medical Devices  Other Health  General Health

MEDIA:

Logo
 Logo

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.